Your session is about to expire
← Back to Search
Control for Ischemic Stroke (TWIST Trial)
TWIST Trial Summary
This trial will test whether thrombolysis with tenecteplase is effective and safe in patients with wake-up stroke.
- Ischemic Stroke
- Stroke
TWIST Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTWIST Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 4 trial • 200 Patients • NCT01342510TWIST Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Do we have any historical data to support the use of Tenecteplase?
"Currently, there are 15 ongoing clinical trials studying the efficacy of Tenecteplase. 12 of those trials are in the latter stages (Phase 3). The many studies for Tenecteplase are primarily based in Beijing, but there are 426 locations running trials globally."
Is this research project still taking on new participants?
"Yes, this study is actively recruiting patients, according to the information on clinicaltrials.gov. The trial was first posted on 2017-06-12 and was last updated on 2021-05-11."
What have been the side effects of Tenecteplase in past patients?
"There is some data to support the efficacy of Tenecteplase and it has undergone multiple rounds of testing to ensure its safety, so it received a score of 3."
Share this study with friends
Copy Link
Messenger